Zobrazeno 1 - 10
of 44 100
pro vyhledávání: '"Economic-evaluation"'
Autor:
Eisenberg, Daniel, author
Publikováno v:
Investing in Children's Mental Health, 2024.
Externí odkaz:
https://doi.org/10.1093/oso/9780190942014.003.0002
Publikováno v:
International Journal of Emergency Services, 2024, Vol. 13, Issue 3, pp. 259-270.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/IJES-03-2024-0020
Publikováno v:
Medical Devices: Evidence and Research, Vol Volume 17, Pp 471-490 (2024)
Vasily Lukyanov,1 Purvee Parikh,2 Manish Wadhwa,2 Alexandria Dunn,2 Roderick van Leerdam,1 Johan Engdahl,3 Goran Medic1 1Chief Medical Office, Philips Healthcare, Eindhoven, Netherlands; 2Chief Medical Office, Philips, San Diego, CA, USA; 3Karolinska
Externí odkaz:
https://doaj.org/article/08d920c8e8e043d4bdd23c8b19efa4bc
Autor:
Steven Simoens, Sandy Tubeuf, Nicolas Dauby, Olivier Ethgen, Sophie Marbaix, Marjan Willaert, Jeroen Luyten
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 779-788 (2024)
Background As the societal value of vaccines is increasingly recognized, there is a need to examine methodological approaches that could be used to integrate these various benefits in the economic evaluation of a vaccine.Research design and methods A
Externí odkaz:
https://doaj.org/article/c9fe6e49ea2f4020a02eecd9f8d0d35b
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 655-673 (2024)
Introduction The global measles incidence has decreased from 145 to 49 cases per 1 million population from 2000 to 2018, but evaluating the economic benefits of a second measles-containing vaccine (MCV2) is crucial. This study reviewed the evidence a
Externí odkaz:
https://doaj.org/article/f4dde6663d364afeb9ed639b92d868b9
Autor:
Renata Linertová, Aránzazu Hernández-Yumar, Carmen Guirado-Fuentes, Benjamín Rodríguez-Díaz, Cristina Valcárcel-Nazco, Iñaki Imaz-Iglesia, Montserrat Carmona-Rodríguez, Lidia García-Pérez
Publikováno v:
Archives of Public Health, Vol 82, Iss 1, Pp 1-12 (2024)
Abstract Background Cost-effectiveness analyses of health technologies have become a part of the decision-making process in healthcare policies. Nevertheless, economic results are not always presented in comprehensible formats for non-technical audie
Externí odkaz:
https://doaj.org/article/566b05fcc40b45849825b98e3c55ffeb
Publikováno v:
Journal of Oral Biology and Craniofacial Research, Vol 14, Iss 6, Pp 802-807 (2024)
Objective: To identify the trends of the top 100 cited articles on economic evaluation in preventive oral health programs. Methods: Top 100 papers involving economic evaluation or cost analysis of preventive oral health programs were selected by quer
Externí odkaz:
https://doaj.org/article/6abc1230b3554b249cb871d1addc1da0
Publikováno v:
BMC Health Services Research, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Health technology assessment uses explicit economic evaluation evidence to support health benefits package design. However, the limited availability of technical expertise, data, and methods has restricted the production of econom
Externí odkaz:
https://doaj.org/article/d43bf301c5c044ddb1f02f3823ad56ed
Autor:
Wenchao Jiang, Zhaowei Hou, Shichun Yao, Xiaolin Wu, Jian Gai, Chunlin Nie, Xu Su, Shouliang Lu, Yunchao Wang, Bin Huang, Chi Dong, Di Liu, Jiang Jiang, Xiaodan Yu, Yane Wang, Jifeng Zhang, Changjiu Zhao, Erlong Yang, Xiaoru He, Guangming Qi, Jingya Li, Yuxiao Ma, Lei Zhang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract Determining the optimal timing for subsequent water flooding in Alkali-Surfactant-Polymer (ASP) flooding is essential to maximizing both the technical and economic outcomes of oilfield blocks. This study identified eight critical parameters
Externí odkaz:
https://doaj.org/article/a8810f90ba464278a5c81b854d932d7c
Autor:
Yalda Metghalchi, Neda Yaghoubi, Nazila Yousefi, Razieh Ahmadi, Alireza Kargar, Marzieh Zargaran, Soheila Rezaei
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 22, Iss 1, Pp 1-10 (2024)
Abstract Background and objective This study aimed to determine the cost-effectiveness of Tocilizumab (TCZ) compared with Adalimumab (ADA) in patients with Rheumatoid Arthritis (RA), who had not responded to methotrexate (MTX), from a societal perspe
Externí odkaz:
https://doaj.org/article/dba3fb76ad7e4499ab2f5d721a6be22e